Usted buscó: effektvariable (Danés - Inglés)

den primære effektvariable var graden af hæmatologisk hovedrespons, rapporteret enten som fuldstændigt hæmatologisk respons, intet tegn på leukæmi, eller remission til cml i kronisk fase, med
the primary efficacy variable was the rate of haematological response, reported as either complete haematological response, no evidence of leukaemia, or return to chronic phase cml using the same criteria as for the study in accelerated phase.

den primære effektvariable var andelen af patienter med komplet respons (cr, defineret som ingen emetisk episode og ingen behovsmedicin) i de første 24 timer efter påbegyndelse af kemoterapi.
the primary efficacy variable was the proportion of patients with a complete response (cr, defined as no emetic episode and no rescue medication) during the first 24 hours after the start of chemotherapy administration.

den primære effektvariable var graden af hæmatologisk hovedrespons, rapporteret enten som fuldstændigt hæmatologisk respons, intet tegn på leukæmi, eller remission til cml i kronisk fase, med anvendelse af samme kriterier som i undersøgelsen med patienter i accelereret fase.
the primary efficacy variable was the rate of haematological response, reported as either complete haematological response, no evidence of leukaemia or return to chronic phase cml using the same criteria as for the study in accelerated phase.

undersøgelsens primære effektvariable var graden af det cytogenetiske hovedrespons (fuldstændigt plus partielt respons, 0­35% ph+ -metafaser i knoglemarven) .
the primary efficacy variable of the study was the rate of major cytogenetic response (complete plus partial response, 0 to 35% ph+ metaphases in the bone marrow) .

den primære effektvariable var graden af hæmatologisk hovedrespons, rapporteret enten som fuldstændigt hæmatologisk respons, intet tegn på leukæmi (f.eks. clearance af blaster fra knoglemarv og blod, men uden fuldstændig restitution i perifert blod som ved fuldstændigt respons) eller remission til cml i kronisk fase.
the primary efficacy variable was the rate of haematological response, reported as either complete haematological response, no evidence of leukaemia (i.e. clearance of blasts from the marrow and the blood, but without a full peripheral blood recovery as for complete responses), or return to chronic phase cml.